
AGL Energy Ltd (ASX: AGL), Cochlear Ltd (ASX: COH), and WiseTech Global Ltd (ASX: WTC) shares have all slumped lower over the past month, likely due to macroeconomic headwinds, weaker energy prices, and shifts in investor sentiment.
Here’s the latest out of the ASX 200 shares, and what brokers expect next.
Brokers rate AGL shares as a SELL
AGL shares are down around 0.1% to $8.31 at the time of writing on Wednesday morning. The ASX energy shares are now down around 4% over the past month and 11% lower year to date.
Over the past month, AGL shares have come under pressure from softer wholesale electricity prices and government regulation changes have also added a layer of uncertainty.
Mild weather, higher renewable energy generation, and battery storage growth are pushing wholesale electricity prices lower and reducing high-price spikes.
At the same time, the government is trying to push for lower costs by introducing price caps and limiting price increases. This could put pressure on AGL’s margins going forward.
Brokers are mostly bearish on the outlook for the power company going forward. Market Index data shows the majority of brokers have a sell rating on AGL shares, and the $9.70 average target price implies a downside of around 16%, at the time of writing.
Brokers rate Cochlear shares as a HOLD
Cochlear shares have also slipped further into the red on Wednesday morning. At the time of writing, the shares are down around 0.2% to $129.99 each. The shares are down 7% over the past month and 50% lower year to date.
The shares fell around 14% in late September after the company announced to the ASX that it had received a class action claim filed against it in the Supreme Court of Victoria.Â
The claim is on behalf of persons who acquired interests in Cochlear shares between 15 August 2025 and 21 April 2026 (inclusive). It relates to Cochlear’s forecast of underlying net profit for FY26.Â
Cochlear said it denies the allegations set out in the claim and will be defending the proceedings. But the news rattled investor confidence and the shares have continued falling ever since.
The update comes off the back of ongoing operational headwinds. Looking ahead to FY27, the ASX healthcare company expects low-single-digit constant currency revenue growth and an underlying net profit between $330 million and $350 million.
According to Market Index data, the majority of brokers have a hold rating on Cochlear shares. The $126.24 average target price implies a downside of around 3% at the time of writing.
Brokers rate WiseTech shares as a BUY
WiseTech shares are also down on Wednesday morning. At the time of writing, the shares have fallen around 0.5% to $31.79 each. Over the past month WiseTech shares have tumbled 12%, and they’re also down 54% for the year-to-date.
There hasn’t been any price sensitive news out of the company over the past month to explain the latest selloff.
But it’s been well-documented that the business has been smashed by a combination of headwinds over the past few months. Including an overall investor rotation away from tech shares, a series of regulatory investigations, and governance concerns.
The company’s FY26 results announcement in August didn’t help confidence either. On the surface the earnings result was positive, and earnings were in line with analyst expectations. But its EBITDA figures came in short of market forecasts and investors rushed to sell up.
But it looks like the experts are still confident that WiseTech shares can bounce back over the next year. Market Index data shows all brokers have a strong buy rating on the shares. The $58.07 target price implies an upside of around 82% at the time of writing.
The post AGL, Cochlear, WiseTech shares: Buy, hold, sell appeared first on The Motley Fool Australia.
Should you invest $1,000 in Agl Energy right now?
Before you buy Agl Energy shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Agl Energy wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 August 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- How much passive income can I earn from a $950,000 superannuation balance?
- Here are the top 10 ASX 200 shares today
- 3 defensive ASX shares I’d buy in a market sell-off
- How much superannuation do I need to earn $56,000 per year in passive income?
- Tech shares shine while ASX 200 plunges to 4-month low
Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

